Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study.

Sabia S, Fayosse A, Dumurgier J, Dugravot A, Akbaraly T, Britton A, Kivimäki M, Singh-Manoux A.

BMJ. 2018 Aug 1;362:k2927. doi: 10.1136/bmj.k2927.

2.

Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension.

Abell JG, Kivimäki M, Dugravot A, Tabak AG, Fayosse A, Shipley M, Sabia S, Singh-Manoux A.

Eur Heart J. 2018 Jun 12. doi: 10.1093/eurheartj/ehy288. [Epub ahead of print]

PMID:
29901708
3.

Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study.

Singh-Manoux A, Fayosse A, Sabia S, Tabak A, Shipley M, Dugravot A, Kivimäki M.

PLoS Med. 2018 May 21;15(5):e1002571. doi: 10.1371/journal.pmed.1002571. eCollection 2018 May.

4.

Testosterone and All-Cause Mortality in Older Men: The Role of Metabolic Syndrome.

Laouali N, Brailly-Tabard S, Helmer C, Ancelin ML, Tzourio C, Singh-Manoux A, Dugravot A, Elbaz A, Guiochon-Mantel A, Canonico M.

J Endocr Soc. 2018 Feb 26;2(4):322-335. doi: 10.1210/js.2018-00005. eCollection 2018 Apr 1.

5.

The gait speed advantage of taller stature is lost with age.

Elbaz A, Artaud F, Dugravot A, Tzourio C, Singh-Manoux A.

Sci Rep. 2018 Jan 24;8(1):1485. doi: 10.1038/s41598-018-19882-1.

6.

Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study.

Singh-Manoux A, Dugravot A, Shipley M, Brunner EJ, Elbaz A, Sabia S, Kivimaki M.

Alzheimers Dement. 2018 Feb;14(2):178-186. doi: 10.1016/j.jalz.2017.06.2637. Epub 2017 Sep 21.

7.

Contribution of cognitive performance and cognitive decline to associations between socioeconomic factors and dementia: A cohort study.

Rusmaully J, Dugravot A, Moatti JP, Marmot MG, Elbaz A, Kivimaki M, Sabia S, Singh-Manoux A.

PLoS Med. 2017 Jun 26;14(6):e1002334. doi: 10.1371/journal.pmed.1002334. eCollection 2017 Jun.

8.

Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study.

Sabia S, Dugravot A, Dartigues JF, Abell J, Elbaz A, Kivimäki M, Singh-Manoux A.

BMJ. 2017 Jun 22;357:j2709. doi: 10.1136/bmj.j2709.

9.

Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study.

Singh-Manoux A, Dugravot A, Fournier A, Abell J, Ebmeier K, Kivimäki M, Sabia S.

JAMA Psychiatry. 2017 Jul 1;74(7):712-718. doi: 10.1001/jamapsychiatry.2017.0660.

10.

Atrial fibrillation as a risk factor for cognitive decline and dementia.

Singh-Manoux A, Fayosse A, Sabia S, Canonico M, Bobak M, Elbaz A, Kivimäki M, Dugravot A.

Eur Heart J. 2017 Sep 7;38(34):2612-2618. doi: 10.1093/eurheartj/ehx208.

11.

Agricultural activities and the incidence of Parkinson's disease in the general French population.

Kab S, Spinosi J, Chaperon L, Dugravot A, Singh-Manoux A, Moisan F, Elbaz A.

Eur J Epidemiol. 2017 Mar;32(3):203-216. doi: 10.1007/s10654-017-0229-z. Epub 2017 Feb 9.

PMID:
28185034
12.

Association of UV radiation with Parkinson disease incidence: A nationwide French ecologic study.

Kravietz A, Kab S, Wald L, Dugravot A, Singh-Manoux A, Moisan F, Elbaz A.

Environ Res. 2017 Apr;154:50-56. doi: 10.1016/j.envres.2016.12.008. Epub 2016 Dec 26.

PMID:
28033496
13.

Powdery Mildew Decreases the Radial Growth of Oak Trees with Cumulative and Delayed Effects over Years.

Bert D, Lasnier JB, Capdevielle X, Dugravot A, Desprez-Loustau ML.

PLoS One. 2016 May 13;11(5):e0155344. doi: 10.1371/journal.pone.0155344. eCollection 2016.

14.

Trajectories of Unhealthy Behaviors in Midlife and Risk of Disability at Older Ages in the Whitehall II Cohort Study.

Artaud F, Sabia S, Dugravot A, Kivimaki M, Singh-Manoux A, Elbaz A.

J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1500-1506. Epub 2016 Mar 30.

15.

Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.

Da Silva MA, Dugravot A, Balkau B, Roussel R, Fumeron F, Elbaz A, Canonico M, Singh-Manoux A, Nabi H; D.E.S.I.R. Study Group.

Int J Epidemiol. 2015 Dec;44(6):1927-40. doi: 10.1093/ije/dyv153. Epub 2015 Aug 4.

PMID:
26245205
16.

Detection of Outliers Due to Participants' Non-Adherence to Protocol in a Longitudinal Study of Cognitive Decline.

Dugravot A, Sabia S, Shipley MJ, Welch C, Kivimaki M, Singh-Manoux A.

PLoS One. 2015 Jul 10;10(7):e0132110. doi: 10.1371/journal.pone.0132110. eCollection 2015.

17.

Decline in Fast Gait Speed as a Predictor of Disability in Older Adults.

Artaud F, Singh-Manoux A, Dugravot A, Tzourio C, Elbaz A.

J Am Geriatr Soc. 2015 Jun;63(6):1129-36. doi: 10.1111/jgs.13442. Epub 2015 Jun 11.

PMID:
26096387
18.

Body mass index trajectories and functional decline in older adults: Three-City Dijon cohort study.

Artaud F, Singh-Manoux A, Dugravot A, Tavernier B, Tzourio C, Elbaz A.

Eur J Epidemiol. 2016 Jan;31(1):73-83. doi: 10.1007/s10654-015-0027-4. Epub 2015 Apr 9.

19.

Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife.

Singh-Manoux A, Dugravot A, Brunner E, Kumari M, Shipley M, Elbaz A, Kivimaki M.

Neurology. 2014 Aug 5;83(6):486-93. doi: 10.1212/WNL.0000000000000665. Epub 2014 Jul 2.

20.

No evidence of a longitudinal association between diurnal cortisol patterns and cognition.

Singh-Manoux A, Dugravot A, Elbaz A, Shipley M, Kivimaki M, Kumari M.

Neurobiol Aging. 2014 Oct;35(10):2239-45. doi: 10.1016/j.neurobiolaging.2014.03.015. Epub 2014 Mar 20.

21.

Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study.

Hinnouho GM, Czernichow S, Dugravot A, Nabi H, Brunner EJ, Kivimaki M, Singh-Manoux A.

Eur Heart J. 2015 Mar 1;36(9):551-9. doi: 10.1093/eurheartj/ehu123. Epub 2014 Mar 26.

22.

Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study.

Tuligenga RH, Dugravot A, Tabák AG, Elbaz A, Brunner EJ, Kivimäki M, Singh-Manoux A.

Lancet Diabetes Endocrinol. 2014 Mar;2(3):228-35. doi: 10.1016/S2213-8587(13)70192-X. Epub 2013 Dec 19.

23.

Alcohol consumption and cognitive decline in early old age.

Sabia S, Elbaz A, Britton A, Bell S, Dugravot A, Shipley M, Kivimaki M, Singh-Manoux A.

Neurology. 2014 Jan 28;82(4):332-9. doi: 10.1212/WNL.0000000000000063. Epub 2014 Jan 15.

24.

Subjective cognitive complaints and mortality: does the type of complaint matter?

Singh-Manoux A, Dugravot A, Ankri J, Nabi H, Berr C, Goldberg M, Zins M, Kivimaki M, Elbaz A.

J Psychiatr Res. 2014 Jan;48(1):73-8. doi: 10.1016/j.jpsychires.2013.10.005. Epub 2013 Oct 14.

25.

Unhealthy behaviours and disability in older adults: three-City Dijon cohort study.

Artaud F, Dugravot A, Sabia S, Singh-Manoux A, Tzourio C, Elbaz A.

BMJ. 2013 Jul 23;347:f4240. doi: 10.1136/bmj.f4240.

26.

Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?

Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A.

Diabetes Care. 2013 Aug;36(8):2294-300. doi: 10.2337/dc12-1654. Epub 2013 May 1.

27.

Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores.

Kaffashian S, Dugravot A, Elbaz A, Shipley MJ, Sabia S, Kivimäki M, Singh-Manoux A.

Neurology. 2013 Apr 2;80(14):1300-6. doi: 10.1212/WNL.0b013e31828ab370.

28.

Informal caregiving and the risk for coronary heart disease: the Whitehall II study.

Buyck JF, Ankri J, Dugravot A, Bonnaud S, Nabi H, Kivimäki M, Singh-Manoux A.

J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1316-23. doi: 10.1093/gerona/glt025. Epub 2013 Mar 22.

29.

Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study.

Kaffashian S, Dugravot A, Brunner EJ, Sabia S, Ankri J, Kivimäki M, Singh-Manoux A.

Alzheimers Dement. 2013 Sep;9(5):572-9. doi: 10.1016/j.jalz.2012.07.001. Epub 2012 Nov 28.

30.

Obesity phenotypes in midlife and cognition in early old age: the Whitehall II cohort study.

Singh-Manoux A, Czernichow S, Elbaz A, Dugravot A, Sabia S, Hagger-Johnson G, Kaffashian S, Zins M, Brunner EJ, Nabi H, Kivimäki M.

Neurology. 2012 Aug 21;79(8):755-62. doi: 10.1212/WNL.0b013e3182661f63.

31.

Socioeconomic status, structural and functional measures of social support, and mortality: The British Whitehall II Cohort Study, 1985-2009.

Stringhini S, Berkman L, Dugravot A, Ferrie JE, Marmot M, Kivimaki M, Singh-Manoux A.

Am J Epidemiol. 2012 Jun 15;175(12):1275-83. doi: 10.1093/aje/kwr461. Epub 2012 Apr 24.

32.

Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study.

Sabia S, Elbaz A, Dugravot A, Head J, Shipley M, Hagger-Johnson G, Kivimaki M, Singh-Manoux A.

Arch Gen Psychiatry. 2012 Jun;69(6):627-35. doi: 10.1001/archgenpsychiatry.2011.2016.

33.

Timing of onset of cognitive decline: results from Whitehall II prospective cohort study.

Singh-Manoux A, Kivimaki M, Glymour MM, Elbaz A, Berr C, Ebmeier KP, Ferrie JE, Dugravot A.

BMJ. 2012 Jan 5;344:d7622. doi: 10.1136/bmj.d7622.

34.

Effect of intensity and type of physical activity on mortality: results from the Whitehall II cohort study.

Sabia S, Dugravot A, Kivimaki M, Brunner E, Shipley MJ, Singh-Manoux A.

Am J Public Health. 2012 Apr;102(4):698-704. doi: 10.2105/AJPH.2011.300257. Epub 2011 Nov 28.

35.

Usefulness of a single-item measure of depression to predict mortality: the GAZEL prospective cohort study.

Lefèvre T, Singh-Manoux A, Stringhini S, Dugravot A, Lemogne C, Consoli SM, Goldberg M, Zins M, Nabi H.

Eur J Public Health. 2012 Oct;22(5):643-7. Epub 2011 Aug 11.

36.

Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study.

Kaffashian S, Dugravot A, Nabi H, Batty GD, Brunner E, Kivimäki M, Singh-Manoux A.

Eur Heart J. 2011 Sep;32(18):2326-32. doi: 10.1093/eurheartj/ehr133. Epub 2011 May 23.

37.

Does cognitive reserve shape cognitive decline?

Singh-Manoux A, Marmot MG, Glymour M, Sabia S, Kivimäki M, Dugravot A.

Ann Neurol. 2011 Aug;70(2):296-304. doi: 10.1002/ana.22391. Epub 2011 May 11.

38.

Health behaviours, socioeconomic status, and mortality: further analyses of the British Whitehall II and the French GAZEL prospective cohorts.

Stringhini S, Dugravot A, Shipley M, Goldberg M, Zins M, Kivimäki M, Marmot M, Sabia S, Singh-Manoux A.

PLoS Med. 2011 Feb;8(2):e1000419. doi: 10.1371/journal.pmed.1000419. Epub 2011 Feb 22.

39.

Trajectories of depressive episodes and hypertension over 24 years: the Whitehall II prospective cohort study.

Nabi H, Chastang JF, Lefèvre T, Dugravot A, Melchior M, Marmot MG, Shipley MJ, Kivimäki M, Singh-Manoux A.

Hypertension. 2011 Apr;57(4):710-6. doi: 10.1161/HYPERTENSIONAHA.110.164061. Epub 2011 Feb 21.

40.

Association of lung function with physical, mental and cognitive function in early old age.

Singh-Manoux A, Dugravot A, Kauffmann F, Elbaz A, Ankri J, Nabi H, Kivimaki M, Sabia S.

Age (Dordr). 2011 Sep;33(3):385-92. doi: 10.1007/s11357-010-9189-x. Epub 2010 Sep 29.

41.

Do different measures of early life socioeconomic circumstances predict adult mortality? Evidence from the British Whitehall II and French GAZEL studies.

Stringhini S, Dugravot A, Kivimaki M, Shipley M, Zins M, Goldberg M, Ferrie JE, Singh-Manoux A.

J Epidemiol Community Health. 2011 Dec;65(12):1097-103. doi: 10.1136/jech.2009.102376. Epub 2010 Jul 30.

42.

Do socioeconomic factors shape weight and obesity trajectories over the transition from midlife to old age? Results from the French GAZEL cohort study.

Dugravot A, Sabia S, Stringhini S, Kivimaki M, Westerlund H, Vahtera J, Guéguen A, Zins M, Goldberg M, Nabi H, Singh-Manoux A.

Am J Clin Nutr. 2010 Jul;92(1):16-23. doi: 10.3945/ajcn.2010.29223. Epub 2010 May 19.

43.

Socioeconomic position and cognitive decline using data from two waves: what is the role of the wave 1 cognitive measure?

Dugravot A, Guéguen A, Kivimaki M, Vahtera J, Shipley M, Marmot MG, Singh-Manoux A.

J Epidemiol Community Health. 2009 Aug;63(8):675-80. doi: 10.1136/jech.2008.081281. Epub 2009 Apr 29.

44.

Hostility and trajectories of body mass index over 19 years: the Whitehall II Study.

Nabi H, Kivimaki M, Sabia S, Dugravot A, Lajnef M, Marmot MG, Singh-Manoux A.

Am J Epidemiol. 2009 Feb 1;169(3):347-54. doi: 10.1093/aje/kwn333. Epub 2008 Nov 20.

45.

The role of conventional risk factors in explaining social inequalities in coronary heart disease: the relative and absolute approaches to risk.

Singh-Manoux A, Nabi H, Shipley M, Guéguen A, Sabia S, Dugravot A, Marmot M, Kivimaki M.

Epidemiology. 2008 Jul;19(4):599-605. doi: 10.1097/EDE.0b013e3181761cdc.

46.

Adult education and child mortality in India: the influence of caste, household wealth, and urbanization.

Singh-Manoux A, Dugravot A, Smith GD, Subramanyam M, Subramanian SV.

Epidemiology. 2008 Mar;19(2):294-301. doi: 10.1097/EDE.0b013e3181632c75.

47.

The association between self-rated health and mortality in different socioeconomic groups in the GAZEL cohort study.

Singh-Manoux A, Dugravot A, Shipley MJ, Ferrie JE, Martikainen P, Goldberg M, Zins M; GAZEL Cohort.

Int J Epidemiol. 2007 Dec;36(6):1222-8. Epub 2007 Nov 19.

Supplemental Content

Loading ...
Support Center